Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-21 Sale | 2023-03-23 7:31 pm | Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer | 144,911 | $3.7256 | $539,879 | 778,997 (Direct) | View |
| 2022-08-09 Sale | 2022-08-11 4:55 pm | Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 550,000 | $13.03 | $7,166,610 | 12,530,909 (Indirect Direct) | View |
| 2021-06-22 Purchase | 2021-06-23 4:41 pm | Century Therapeutics Inc. | IPSC | BAYER AKTIENGESELLSCHAFT Bayer World Investments B.V. 10% Owner | 750,000 | $20 | $15,000,000 | 12,675,838 (Direct) | View |
| 2021-06-22 Purchase | 2021-06-23 4:30 pm | Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 100,000 | $20 | $2,000,000 | 13,630,909 (Indirect Direct) | View |
| 2021-06-22 Purchase | 2021-06-22 4:31 pm | Century Therapeutics Inc. | IPSC | Casdin Eli Director | 750,000 | $20 | $15,000,000 | 3,206,380 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-21 Exercise | 2023-03-23 7:31 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer | 350,244 | $1.03 | 778,997 (Direct) | View |
| 2023-03-21 Exercise | 2023-03-23 7:31 pm | N/A 2029-07-17 | Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer | 350,244 | $0 | 778,997 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 6:52 pm | N/A 2033-02-02 | Century Therapeutics Inc. | IPSC | Flores Osvaldo Chief Executive Officer | 1,275,000 | $0 | 1,275,000 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 6:52 pm | N/A 2033-02-02 | Century Therapeutics Inc. | IPSC | Carr Douglas VP Finance & Operations | 97,500 | $0 | 290,545 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 6:51 pm | N/A 2033-02-02 | Century Therapeutics Inc. | IPSC | Russotti Gregory Chief Technology Officer | 350,000 | $0 | 350,000 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 6:50 pm | N/A 2033-02-02 | Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer | 284,375 | $0 | 306,250 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 6:49 pm | N/A 2033-02-02 | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 284,375 | $0 | 380,468 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 6:49 pm | N/A 2033-02-02 | Century Therapeutics Inc. | IPSC | Diem Michael Craig Chief Business Officer | 284,375 | $0 | 385,738 (Direct) | View |
| 2022-10-01 Option Award | 2022-10-03 4:08 pm | N/A 2032-10-01 | Century Therapeutics Inc. | IPSC | Quimi Daphne Director | 39,744 | $0 | 39,744 (Direct) | View |
| 2022-10-01 Option Award | 2022-10-03 4:07 pm | N/A 2032-10-01 | Century Therapeutics Inc. | IPSC | Walbert Timothy P Director | 39,744 | $0 | 39,744 (Direct) | View |
| 2022-08-09 Other | 2022-08-11 4:55 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 364,800 | $0 | 12,530,909 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:23 pm | N/A 2032-06-09 | Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director | 19,872 | $0 | 19,872 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:23 pm | N/A 2032-06-09 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 19,872 | $0 | 19,872 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:23 pm | N/A 2032-06-09 | Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director | 19,872 | $0 | 19,872 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:22 pm | N/A 2032-06-09 | Century Therapeutics Inc. | IPSC | Casdin Eli Director | 19,872 | $0 | 19,872 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:22 pm | N/A 2032-06-09 | Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director | 19,872 | $0 | 19,872 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:21 pm | N/A 2032-06-09 | Century Therapeutics Inc. | IPSC | Carlo Rizzuto Director | 19,872 | $0 | 19,872 (Direct) | View |
| 2022-01-31 Other | 2022-02-02 4:31 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 178,996 | $0 | 13,259,905 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:51 pm | N/A 2032-01-25 | Century Therapeutics Inc. | IPSC | Diem Michael Craig Chief Business Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:51 pm | N/A 2032-01-25 | Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:50 pm | N/A 2032-01-25 | Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:50 pm | N/A 2032-01-25 | Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D | 105,000 | $0 | 105,000 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:50 pm | N/A 2032-01-25 | Century Therapeutics Inc. | IPSC | Russotti Gregory Chief Technology Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:49 pm | N/A 2032-01-25 | Century Therapeutics Inc. | IPSC | Flores Osvaldo Chief Executive Officer | 315,000 | $0 | 315,000 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 4:49 pm | N/A 2032-01-25 | Century Therapeutics Inc. | IPSC | Carr Douglas VP of Finance and Operations | 35,000 | $0 | 35,000 (Direct) | View |
| 2021-12-23 Other | 2021-12-28 4:46 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 371,004 | $0 | 13,630,909 (Direct) | View |
| 2021-06-22 Conversion | 2021-06-23 5:00 pm | N/A N/A | Century Therapeutics Inc. | IPSC | FUJIFILM Cellular Dynamics Inc. FUJIFILM Corp FUJIFILM Holdings America Corp FUJIFILM Holdings Corp 10% Owner | 13,974,404 | $0 | 6,955,207 (Direct) | View |
| 2021-06-22 Conversion | 2021-06-23 4:41 pm | N/A N/A | Century Therapeutics Inc. | IPSC | BAYER AKTIENGESELLSCHAFT Bayer World Investments B.V. 10% Owner | 41,932,441 | $0 | 12,675,838 (Direct) | View |
| 2021-06-22 Conversion | 2021-06-23 4:30 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner | 37,095,231 | $0 | 13,630,909 (Direct) | View |
| 2021-06-22 Conversion | 2021-06-22 4:31 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Casdin Eli Director | 8,636,880 | $0 | 3,206,380 (Indirect) | View |
| 2021-06-17 Option Award | 2021-06-21 4:34 pm | N/A 2031-06-17 | Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director | 19,872 | $0 | 19,872 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:33 pm | N/A 2031-06-17 | Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director | 19,872 | $0 | 19,872 (Direct) | View |
| 2021-06-17 Disposition | 2021-06-21 4:33 pm | N/A 2031-06-17 | Century Therapeutics Inc. | IPSC | Casdin Eli Director | 39,744 | $0 | 39,744 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:32 pm | N/A 2031-06-17 | Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director | 19,872 | $0 | 19,872 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:32 pm | N/A 2031-06-17 | Century Therapeutics Inc. | IPSC | Carlo Rizzuto Director | 39,744 | $0 | 39,744 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:31 pm | N/A 2031-06-17 | Century Therapeutics Inc. | IPSC | Riva Alessandro Director | 19,872 | $0 | 19,872 (Direct) | View |
Ownership | 2021-06-17 5:50 pm | N/A N/A | Century Therapeutics Inc. | IPSC | BAYER AKTIENGESELLSCHAFT Bayer World Investments B.V. 10% Owner | 0 | $0 | 11,925,838 (Direct) | View |
Ownership | 2021-06-17 5:28 pm | N/A N/A | Century Therapeutics Inc. | IPSC | FUJIFILM Cellular Dynamics Inc. FUJIFILM Corp FUJIFILM Holdings America Corp FUJIFILM Holdings Corp 10% Owner | 0 | $0 | 6,955,207 (Direct) | View |
Ownership | 2021-06-17 5:09 pm | N/A N/A | Century Therapeutics Inc. | IPSC | Casdin Eli Director | 0 | $0 | 2,456,380 (Indirect) | View |